CHRONIC OBSTRUCTIVE PULMONARY DISEASE Major Killer disease in the world Chronic progressive disease of the lung caused by inhalation of toxic substances.

Slides:

Advertisements

Similar presentations

Use of solid fuels MICS3 Data Analysis and Report Writing Workshop.

Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.

Exposure to Particulate Matter from Kerosene Lamps James Apple, Ryan Vicente, Andrea Yarberry, Nathan Lohse, Jenny Tracy and Dustin Poppendieck, Ph.D.

BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.

REDUCING RESPIRATORY ILLNESS THROUGH ALLEVIATING KITCHEN SMOKE IRISH FORUM FOR GLOBAL HEALTH (IFGH) BIENNIAL CONFERENCE November 29 th 2010 Liz Bates.

Case Study: Costing the Health Impacts of Air Pollution in Bristol Dr Clare Beattie.

Evaluation of the Costs and Benefits of Household Energy and Health Interventions 31 st IAEE International Conference, Pre-Conference Workshop on Clean.

Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp

Prof Dr Guy JOOS Dept Respiratory Diseases Ghent University Hospital

Burden of COPD Société Belge de Pneumologie Belgische Vereniging voor Pneumologie Danny Galdermans.

Indoor & Outdoor Air Pollution Student Number:

CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.

©LTPHN 2008 Respiratory Diseases Name Speaker. ©LTPHN 2008 Respiratory Disease – Global Burden Very common worldwide Substantial preventable morbidity.

Faculty Research Advisor: Dr. David Blake. Background Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and.

Injuries and violence: the global magnitude Etienne Krug Director, Violence and Injury Prevention and Disability World Health Organization.

THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.

Gaynor Guthrie Medical Inspector

Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,

HEALTHY CARIBBEAN 2008 Revolutionizing the Prevention and Management of Lung Disease Dr. Timothy Roach FRCP FACP Head, Respiratory Unit Queen Elizabeth.

Chronic Obstructive Pulmonary Disease

UN Commission on Sustainable Development, 14 th Session Partnerships Fair, 2 May 2006 Eva Rehfuess Programme on Indoor Air Pollution World Health Organization.

Task Force on Health - a short update 19th EIONET workshop on AQ assessment Bern 1 October 2014 Frank de Leeuw, Valentin Foltescu ETC/Air Pollution and.

Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.

WORLD HEALTH ORGANIZATION Source: World Health Report 2000 JS 3/01 WHO Statistics, 2000 Dr. Rüdiger Krech A/Regional Adviser, Healthy Ageing World Health.

Similarities and differences between developing countries and Australia Chapter 8.2.

The Negative Impact of Air pollution on Respiratory Health Dr Des Murphy Consultant Respiratory Physician CUH.

Global and Regional estimates of the Burden Due to Ambient Air Pollution: results from GBD ST AFRICA/MIDDLE-EAST EXPERT MEETING AND WORKSHOP ON THE.

Chronic Obstructive Pulmonary Disease Austin Paul K.

Burden of chronic diseases Giovanni Viegi, MD. Director of Research, Italian National Research Council. Head, Pulmonary Environmental Epidemiology Unit,

COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.

Meeting the Challenge of Non-Communicable Diseases Lecture 14.

Factors Affecting Access to Safe Drinking Water.

CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.

Time-series studies for the relationship between air pollution and the population health in Beijing Xiao-chuan Pan Dept. of Occupational and Environmental.

COPD Local Burden The Philippines. COPD A Global Health Concern COPD a growing cause of morbidity & mortality worldwide 5 th leading cause of death (2002)

Contents Key facts What is COPD Prevalence of COPD by age Hospitalisation trends Hospitalisation seasonality COPD deaths and smoking rates, COPD.

Environmental Health and Toxicology Introductory Lecture.

An intracellular mycotic infection of the reticuloendothelial system caused by the inhalation of the fungus. Approximately 95% of cases of histoplasmosis.

Health, Happiness & Community Sing Your Lungs Out Study Group; Medical Research Institute of New Zealand Dr Amanda McNaughton, Dr Sarah Aldington, Gayle.

COPD Therapeutics in Asia-Pacific Markets to 2022-Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies Phone No.:

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.

Chronic respiratory diseases: burden, population and interventions,

Construction Dusts: Much more than a Nuisance!

deaths per year (2013 WHO estimates)

How does teamwork improve value. Dr Nils E

Peter Burney National Heart and Lung Institute

Influencing on air policy – a PHE perspective through three documents

Respiratory Disorders

The unrecognized epidemic IN INDIA

Sources: (1) Global Strategy for the diagnosis Management and Prevention of COPD, Global initiative for Chronic Obstructive Lung Disease (GOLD)

Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital

DYSLIPIDEMIA AND ATHEROSCLEROSIS

Chronic obstructive pulmonary disease (COPD)

Unit 3 Notes: Respiratory Disorders

Respiratory System Disorders

THE ENERGY ACCESS SITUATION IN DEVELOPING COUNTRIES

Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.

Global burden of hypertension in the adult population

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

WHO Statistics, 2000 Dr. Rüdiger Krech

“The more there are suffering, then the more natural their sufferings appear. Who wants to prevent the fish in the sea from getting wet? Bertolt Brecht.

Figure 1 Hazard ratios as a function of annual mean PM2

Age-dependent health risk from ambient air pollution: a modelling and data analysis of childhood mortality in middle-income and low-income countries

Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.

Volume 103, Issue 6, Pages (June 1993)

PM2·5: an important cause for chronic obstructive pulmonary disease?

A Time of Commitments and Actions to accelerate action to End TB

BPCO: concetti base 1.

Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)

Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.

Presentation transcript:

CHRONIC OBSTRUCTIVE PULMONARY DISEASE Major Killer disease in the world Chronic progressive disease of the lung caused by inhalation of toxic substances and chronic infective lung diseases like tuberculosis 4 th leading cause of death worldwide, and estimated to become 3 rd leading cause of death by Also causes immense suffering, and a huge economic loss for the country (India loses 7.5 billion US $ per year due to COPD)

Causes of COPD

COPD WORKING GROUP Study the prevalence of COPD using standardized global research tools Link with BOLD (Burden of Chronic Obstructive Lung Disease) Study the effects of indoor air pollution on lung Help determine policy for health interventions Workshop tomorrow, 28th Oct 2009, 4.00 pm Will be Chaired by Dr Sonia Buist, USA (BOLD Chair)